Ironwood Pharmaceuticals, Inc(NASDAQ:IRWD) 
Ironwood Pharmaceuticals, Inc., a healthcare company, focuses on the development and commercialization of gastrointestinal (GI) products. It markets linaclotide, a guanylate cyclase type-C agonist for the treatment of adults suffering from irritable bowel syndrome with constipation (IBS-C) or chroni...
Website: http://www.ironwoodpharma.com
Founded: 1998
Full Time Employees: 317
Sector: Healthcare
Industry: Drug Manufacturers-Specialty & Generic
The information provided in this report is taken from www.sec.gov. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Day
Week
Month
Date 2025-04-04
P
O 1.29
H 1.36
L 1.25
C 1.34
V 1,832,054
10EMA 1.34
20EMA 1.34
60EMA 1.34
120EMA 1.34
250EMA 1.34